Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:11 PM UTC
| NCT Number | NCT07303907 |
| Recruiting Status | Recruiting |
| Condition | Autism Spectrum Disorder |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Definium Therapeutics US, Inc. |
| Last Updated on CT.gov | April 6, 2026 (Apr 6, 2026) |
As of July 16, 2026: Clinical trial NCT07303907 is currently recruiting participants. This phase2 study for autism spectrum disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Definium Therapeutics US, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07303907 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07303907 was last updated Apr 6, 2026 (April 6, 2026). HelloStudys verifies this status automatically.